Who owns Tempest Therapeutics Inc?
- Ticker: TPST
- CUSIP Number: 87978u207
Tip: Access positions for across all investors
Analyze quarterly positions in Tempest Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Tempest Therapeutics stock
Who bought or sold Tempest Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Sabby Management | 511k | $568k | 2763% | Jun 2026 |
|
| Vanguard Capital Management | 234k | $260k | 0% | Jun 2026 |
|
| Geode Capital Management | 87k | $96k | 0% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 69k | $77k | 0% | Jun 2026 |
|
| BlackRock | 39k | $43k | 0% | Jun 2026 |
|
| Squarepoint Ops | 31k | $34k | 100% | Jun 2026 |
|
| Northern Trust | 20k | $22k | 43% | Jun 2026 |
|
| Citadel Advisors | 20k | $22k | 100% | Jun 2026 |
|
| UBS Group | 5.6k | $6.3k | 24% | Jun 2026 |
|
| Tower Research Capital | 3.9k | $4.4k | 41% | Jun 2026 |
|
| Morgan Stanley | 2.1k | $3.4k | 0% | Mar 2026 |
|
| Advisor Group Holdings | 1.5k | $1.7k | -1% | Jun 2026 |
|
| Federation des caisses Desjardins du Quebec | 292.00 | $324.003200 | 0% | Jun 2026 |
|
| Jones Financial Companies, L.L | 239.00 | $258.000500 | 0% | Jun 2026 |
|
| Barclays | 222.00 | $245.998200 | 100% | Jun 2026 |
|
| SBI Securities | 56.00 | $61.997600 | 0% | Jun 2026 |
|
| Royal Bank of Canada | 28.00 | $0 | 4% | Jun 2026 |
|
| Parallel Advisors | 18.00 | $19.999800 | 0% | Jun 2026 |
|
| Citigroup | 8.00 | $13.000000 | 100% | Mar 2026 |
|
| Caitong International Asset Management | 3.00 | $3.000000 | 100% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 3.00 | $3.000000 | 0% | Jun 2026 |
|
Who sold out of Tempest Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| FMR | Mar 2026 | 33k | $55k |
| Dimensional Fund Advisors | Mar 2026 | 11k | $19k |
| Vanguard Global Advisers | Mar 2026 | 168.00 | $276.007200 |